Researchers in Iran are conducting a clinical trial to test the effects of taking ginger supplements for people with…
Articles by Marisa Wexler, MS
Multiple Sclerosis News Today brought consistent coverage of the latest scientific research, developments in treatment, and clinical trials for…
Severing the lower part of the vagus nerve — one of the main neurological pathways that connects the brain to…
Foralumab, a nasal spray therapy that Tiziana Life Sciences is developing for multiple sclerosis (MS) and other disorders,…
Researchers have created a computer program that can simulate clinical trial responses for relapsing-remitting multiple sclerosis (RRMS), which may…
Genetic variations in certain genes may increase the risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection…
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive…
Daily exposure to 30 minutes of bright light for two weeks led to clinically significant reductions in fatigue scores…
A machine learning algorithm that incorporates genetic data alongside clinical and demographic information may be able to more accurately predict…
Researchers have developed a technique that uses CAR T-cells, a form of cell therapy, to specifically eliminate the self-reactive immune…
Differences in the composition of the gut microbiome are associated with an altered risk of low immune cell counts as…
Assessing disease activity from the first to second year after a diagnosis of multiple sclerosis (MS), once treatment has…
Posterior tibial nerve stimulation (PTNS) — a procedure that delivers electrical stimulation to the bladder through nerves in the leg…
Blocking the activity of Spns2, a transporter of the sphingosine 1-phosphate (S1P) protein, reduced the severity of multiple sclerosis…
People with relapsing-remitting multiple sclerosis (RRMS) who switch to Ocrevus (ocrelizumab) after discontinuing Gilenya (fingolimod) have fewer relapses…
A dietary supplement called Neuroaspis plp10 significantly lowered relapse rates and slowed disability progression among people with relapsing-remitting multiple sclerosis…
An international panel is calling for new methods to classify multiple sclerosis (MS) that reflect the disease’s underlying biology,…
A team of doctors, researchers, and patients has come up with a set of recommendations to help medical professionals in…
Most adults with relapsing-remitting multiple sclerosis (RRMS) who received Immunic Therapeutics‘ investigational therapy vidofludimus calcium have had…
Among people with type 2 diabetes, the use of anti-hyperglycemic medications is associated with a reduced risk of…
Using a new approach to track signals traveling between different brain regions, researchers found that these signals are slower in…
Following an autologous hematopoietic stem cell transplant (aHSCT) in people with multiple sclerosis (MS), the population of “naïve” T-cells…
Timing doses of rituximab by measuring B-cell counts is a more tailored approach to treatment, and it effectively reduces relapses and…
Dietary interventions may help ease fatigue and improve quality of life in people with multiple sclerosis (MS), although it…
Measuring how lesions get bigger over time in multiple sclerosis (MS) can predict long-term disability progression more accurately…
Multiple sclerosis (MS) patients with minimal to moderate disability live about 30 additional years after their diagnosis, but life…
Note: This story was updated Oct. 31, 2022, to correct that in the six months after treatment discontinuation, relapses were…
Trethera has been awarded a $1.6 million grant to further develop TRE-515 as a potential treatment for optic neuritis…
Measuring disability progression every time it occurs, rather than just tracking whether it occurs, could improve the statistical power of…
A protein called spleen tyrosine kinase (SYK) is critical for microglia, the brain’s immune cells, to clear the toxic debris…